Assignee
GLOBAL BLOOD THERAPEUTICS INC
US·58 granted patents·49 pending applications·827 citations·filing 2012–2024
Top patents by PatentIndex Score
107 records- 0199US10034879B2Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jul 31, 2018·36 cites·2 claims
- 0299US10017491B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jul 10, 2018·34 cites·1 claims
- 0398US10683285B2Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Jun 16, 2020·31 cites·20 claims
- 0498US10450269B1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Oct 22, 2019·26 cites·14 claims
- 0598US10377741B2Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·15 cites·5 claims
- 0698US9776960B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Oct 3, 2017·44 cites·15 claims
- 0798US9447071B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·36 cites·33 claims
- 0898US9422279B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Aug 23, 2016·50 cites·25 claims
- 0998US9248199B21:1 adducts of sickle hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Feb 2, 2016·43 cites·2 claims
- 1098US9018210B2Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2012·Granted Apr 28, 2015·56 cites·6 claims
- 1197US10137118B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Nov 27, 2018·20 cites·6 claims
- 1297US9957250B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·19 cites·6 claims
- 1397US9802900B2Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 31, 2017·39 cites·20 claims
- 1497US9458139B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Oct 4, 2016·45 cites·24 claims
- 1597US8952171B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Feb 10, 2015·52 cites·19 claims
- 1696US10695330B2Methods of treatmentGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Jun 30, 2020·12 cites·17 claims
- 1796US9604999B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Mar 28, 2017·45 cites·3 claims
- 1895US11548880B2Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Jan 10, 2023·3 cites·20 claims
- 1995US10315991B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jun 11, 2019·14 cites·3 claims
- 2094US10577345B2Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Mar 3, 2020·12 cites·17 claims
- 2194US10435393B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Oct 8, 2019·14 cites·11 claims
- 2294US10100043B2Substituted aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·15 cites·26 claims
- 2394US10077249B2Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Sep 18, 2018·24 cites·36 claims
- 2494US9012450B2Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2012·Granted Apr 21, 2015·46 cites·14 claims
- 2593US9981939B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted May 29, 2018·17 cites·7 claims
- 2692US10100040B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·18 cites·21 claims
- 2790US10266551B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Apr 23, 2019·16 cites·21 claims
- 2890US10004725B2Methods of treatmentGLOBAL BLOOD THERAPEUTICS INC·Filed 2016·Granted Jun 26, 2018·18 cites·6 claims
- 2989US11746100B2Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·2 cites·48 claims
- 3088US10806733B2Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Oct 20, 2020·1 cites·7 claims
- 3188US2025032471A1Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3287US11452720B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·1 cites·14 claims
- 3387US10493035B2Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Dec 3, 2019·15 cites·9 claims
- 3484US10722502B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·1 cites·3 claims
- 3584US2023255963A1Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3682US2022395492A1Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3780US11014884B2Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·2 cites·60 claims
- 3879US11254651B2Histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Feb 22, 2022·2 cites·20 claims
- 3979US2023322704A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4078US2025109122A1Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4178US2022125786A1Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4277US2022135533A1Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4376US12473277B2Solid forms of a modulator of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Granted Nov 18, 2025·0 cites·22 claims
- 4476US11111243B2Azaindole compounds as histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Sep 7, 2021·1 cites·20 claims
- 4576US2023159507A1Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4676US2023219922A1Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4775US12202817B2Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Granted Jan 21, 2025·0 cites·27 claims
- 4875US11530191B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·0 cites·4 claims
- 4975US2021290619A1Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5074US11286243B2Ferroportin inhibitors and methods of useGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Mar 29, 2022·1 cites·24 claims
Showing the top 50 of 107 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →